Cellmid 2017 Annual Report

NOTES TO THE

FINANCIAL STATEMENTS

CONTINUED

8. EARNINGS PER SHARE

Accounting Policy

Basic earnings per share

Basic earnings per share is calculated by dividing the proﬁt or loss attributable to owners of Cellmid Limited, excluding any

costs of servicing equity other than ordinary shares, by the weighted average number of ordinary shares outstanding during the

ﬁnancial year, adjusted for bonus elements in ordinary shares issued during the ﬁnancial year.

Diluted earnings per share

Diluted earnings per share adjusts the ﬁgures used in the determination of basic earnings per share to take into account the

after income tax effect of interest and other ﬁnancing costs associated with dilutive potential ordinary shares and the weighted

average number of shares assumed to have been issued for no consideration in relation to dilutive potential ordinary shares.

Details relating to options are set out in Note 18.

9. CASH AND CASH EQUIVALENTS

Accounting Policy

Cash and cash equivalents include cash on hand, deposits available on demand with banks, other short term highly liquid

investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are reported within short

term borrowings in current liabilities in the consolidated statement of ﬁnancial position.

2017 2016

$ $

Basic and diluted earnings per share (in cents) (0.44) (0.38)

Reconciliation of earnings to proﬁt or loss from continuing operations

Loss for the year attributable to the owners of Cellmid Limited (4,470,136) (3,498,916)

Weighted average number of ordinary shares used in calculating basic No. No.

and dilutive earnings per share 1,020,158,965 910,130,745

Consolidated

2017 2016

$ $

Cash at bank and in hand 3,994,641 2,686,329

The effective interest rate on short term bank deposits at 30 June 2017 was 1.75 % (2015: 2.65%); these deposits were all at call.

Reconciliation of cash

Cash and cash equivalents reported in the statement of cash ﬂows are reconciled to the equivalent items in the statement of

ﬁnancial position as follows:

Cash and cash equivalents 3,994,641 2,686,329

Consolidated